Compare AbCellera Biologics Inc (ABCL) vs Cincinnati Financial Corporation (CINF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Cincinnati Financial Corporation — how do they compare? AbCellera Biologics Inc trades at $9.11 (market cap $2.99B), while Cincinnati Financial Corporation trades at $173.45 (market cap $26.58B). The key difference: Cincinnati Financial Corporation is far larger — about 8.9× AbCellera Biologics Inc's market cap, and Cincinnati Financial Corporation pays a 2.17% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | CINF | |
|---|---|---|
Market Cap | $2.99B | $26.58B |
Sector | Health | Financials |
52-Week High | $9.76 | $192.03 |
52-Week Low | $2.78 | $149.79 |
Enterprise Value | $2.58B | $25.71B |
Dividend Yield | — | 2.17% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Cincinnati Financial Corporation
Cincinnati Financial Corp is a property and casualty insurance company that generates income through written premiums. A select group of independent agencies actively markets the company's business, home, and automotive insurance within their communities. These agents offer the company's personal lines as well as its standard market, excess, and surplus commercial line policies in many regions in the United States. Cincinnati Financial also offers leasing and financing services. The vast majority of the company's revenue is generated through commercial lines, followed by personal lines.
Read more on CINF →
